Escalier Biosciences B.V.

https://www.escalierbio.com

Escalier Biosciences BV is a privately held biopharmaceutical company developing novel small molecule therapeutics that target ROR?t for the treatment of psoriasis and other autoimmune disorders. Escalier’s lead topical and oral drug candidates are currently in late stage preclinical studies. Escalier is registered in The Netherlands with offices in Nijmegen, The Netherlands and Encinitas, California. *

	Start	2016-01-01 established
	Group	Escalier Biosciences (Group)
	Industry	BIOTECH
	Industry 2	ROR gamma inhibitor (orphan nuclear receptor gamma inhibitor)
	Person	Mohan, Raju (Ventyx Biosciences 202103 CEO + Founder before Escalier Biosciences + Akarna Therapeutics)
	Person 2	Krueger, Chris (Escalier Biosciences 201803 CBO)

	Region	Nijmegen
	Country	Netherlands
	Street	5J Transistorweg
	City	6534 AT Nijmegen
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Escalier Biosciences B.V.. (3/13/18). "Press Release: Escalier Biosciences Raises $19 Million to Develop Its Topical and Systemic RORyt Therapies for Psoriasis and other Autoimmune Diseases". Nijmegen.

		Record changed: 2024-02-12

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Escalier Biosciences (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]